BioAmber (BIOA) Misses Q4 EPS by 5c

BioAmber (NYSE: BIOA) reported Q4 EPS of ($0.40), $0.05 worse than the analyst estimate of ($0.35). Revenue for the quarter came in at $1.11 million versus the consensus estimate of $830 thousand.

For earnings history and earnings-related data on BioAmber (BIOA) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• CVG to join Russell 2000 and Russell 3000 indexes June 26
• FedEx (FDX) Tops Q4 EPS by 39c, Beats on Revenue; Offers FY27 EPS Guidance